| SZ CAT No: | CL-DXPZ-12 |
| CAS No: | NA |
| Mol.F: | C17H16F3N3O3S |
| Mol.Wt.: | 399.4 |
| Chemical Name: | 2-((2-(3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)sulfonyl)-1H-benzo[d]imidazole |
| SMILES: | Cc1c(CC[S](=O)(=O)c2[nH]c3ccccc3n2)nccc1OCC(F)(F)F |
| Inventory Status: | In Stock |
This impurity is related to Dexlansoprazole Impurity 9 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Dexlansoprazole Impurity 9 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:2-((2-(3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)sulfonyl)-1H-benzo[d]imidazoleCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Dexlansoprazole Molecular Formula: C17H16F3N3O3S
Molecular Weight: 399.4
Storage: Store in a cool, dry place.
Cat. No: CL-DXPZ-NO-01
CAS No: NA
Mol. F: C16H13F3N4O3S
Mol. Wt: 398.1
Inv. Status: Justification
Cat. No: CL-DXPZ-01
CAS No: 138530-94-6
Mol. F: C16H14F3N3O2S
Mol. Wt: 369.4
Inv. Status: In Stock
Cat. No: CL-DXPZ-02
CAS No: NA
Mol. F: C13H10N3O2
Mol. Wt: 240.2
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-03
CAS No: NA
Mol. F: C15H13N3OS
Mol. Wt: 283.3
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-04
CAS No: NA
Mol. F: C31H25F3N6O2S
Mol. Wt: 602.6
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-05
CAS No: 1409978-52-4
Mol. F: C16H14F3N3O
Mol. Wt: 321.3
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-06
CAS No: 1781244-56-1
Mol. F: C23H16F3N5OS
Mol. Wt: 467.5
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-07
CAS No: 102804-87-5
Mol. F: C15H14N3OS
Mol. Wt: 284.4
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-08
CAS No: NA
Mol. F: C16H15N3OS
Mol. Wt: 297.4
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-09
CAS No: NA
Mol. F: C16H11F3N3OS
Mol. Wt: 350.3
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-10
CAS No: 1427429-03-5
Mol. F: C16H14F3N3O3S
Mol. Wt: 385.4
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-11
CAS No: 853950-77-3
Mol. F: C14H12N4O3S
Mol. Wt: 316.3
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-13
CAS No: NA
Mol. F: C16H13F3N4O3S
Mol. Wt: 398.4
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-14
CAS No: 313640-86-7
Mol. F: C16H14F3N3O2S : 3/2(H2O)
Mol. Wt: 369.4 : 3/2(18.0)
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-15
CAS No: 2730135-07-4
Mol. F: C16H15F3N3O
Mol. Wt: 322.3
Inv. Status: Custom Synthesis
Cat. No: CL-DXP-NO-02
CAS No: NA
Mol. F: C13H9N4O3+
Mol. Wt: 269.2
Inv. Status: Custom Synthesis
Cat. No: CL-DXP-NO-03
CAS No: NA
Mol. F: C15H12N4O2S
Mol. Wt: 312.3
Inv. Status: Custom Synthesis
Cat. No: CL-DXP-NO-04
CAS No: NA
Mol. F: C31H24F3N7O3S
Mol. Wt: 631.6
Inv. Status: Custom Synthesis
Cat. No: CL-DXP-NO-05
CAS No: NA
Mol. F: C16H13F3N4O2
Mol. Wt: 350.3
Inv. Status: Custom Synthesis
Cat. No: CL-DXP-NO-06
CAS No: NA
Mol. F: C16H13F3N4O4S
Mol. Wt: 414.4
Inv. Status: Custom Synthesis
Cat. No: CL-DXP-NO-07
CAS No: NA
Mol. F: C14H11N5O4S
Mol. Wt: 345.3
Inv. Status: Custom Synthesis
Cat. No: CL-DXP-NO-08
CAS No: NA
Mol. F: C17H15F3N4O4S
Mol. Wt: 428.4
Inv. Status: Custom Synthesis
Cat. No: CL-DXP-NO-09
CAS No: NA
Mol. F: C16H14F3N4O2+
Mol. Wt: 351.3
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-16
CAS No: 131926-99-3
Mol. F: C16H14F3N3O3S
Mol. Wt: 385.4
Inv. Status: In Stock
Cat. No: CL-DXPZ-17
CAS No: NA
Mol. F: C11H12F3NO4
Mol. Wt: 279.2
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-18
CAS No: NA
Mol. F: C23H16F3N5OS
Mol. Wt: 467.5
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-19
CAS No: 1409978-46-6
Mol. F: C16H15F3N3O2S
Mol. Wt: 370.4
Inv. Status: Custom Synthesis
Cat. No: CL-DXPZ-20
CAS No: 166521-98-8
Mol. F: C9H10N2O4
Mol. Wt: 210.2
Inv. Status: Custom Synthesis
| CAT No: | CL-DXPZ-12 |
| CAS No: | NA |
| Mol.F: | C17H16F3N3O3S |
| Mol.Wt: | 399.4 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: